In order to confirm the GRP78-dependent binding of Pep42, quantum dots (QD) were conjugated to Mut42 and the nanoparticle formulation was added to the metastatic Me6652/4 cells, and the control, non-metastatic melanoma variant, Me6652/56. Here, HSPA5 is linked to melanoma.